TP53 and cancer: Additionally, the correlation of CYP4X1 expression with various clinicopathological factors, including sample type, individual cancer stage, race, weight, gender, age, histological subtype, nodal metastasis, and TP53 mutation status, showed higher expression in all COAD tissues compared to normal tissues (Figure 1B–J, Table 1).